Structural Heart Devices Market By Type (Heart Valve Devices, Repair Devices, Accessories), By Procedure (Repair Procedures, Replacement Procedures) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Industry Outlook

Over the past three decades, several transcatheter technologies and devices for surgical interventions in structural heart diseases have been introduced to the market. There are several technologies currently under development that use transcatheter intervention techniques. The expansion of percutaneous treatment approaches has resulted in the evolution of clinical care. The previous few years have also witnessed the greater application of new catheter-based treatments for structural heart disease. Several of these interventional procedures have excellent clinical outcomes, therefore gaining greater acceptance among patients and surgeons alike. Advanced imaging technologies have aided in the rapid penetration of minimally invasive interventions for the treatment of structural heart diseases. The introduction of novel imaging technologies has assisted in the precise identification and diagnosis of structural heart diseases for appropriate patient selection for different intervention procedures.

Market Synopsis

Greater demand for heart valve devices is expected to be prominently witnessed during the forecast period.

Based on the type of devices, the global structural heart devices market is segmented into heart valve devices, repair devices, and accessories. Among these, the demand for heart valve devices is set to remain the highest during the forecast period. The market for heart valve devices is significantly large and rapidly growing. It is mainly driven by the continuous adoption and commercialization of new devices and the rapidly growing pool of geriatric cardiovascular disease-affected populations. Increasing amounts of positive clinical evidence are also supporting the demand for heart valve devices. Furthermore, the competitive landscape of this segment is constantly shifting, with small innovator companies being acquired on a regular basis by cash-rich and established market players. The pipeline of heart valve devices is also observed to be strong, with new, long-lasting devices anticipated to be introduced in the coming years.

Replacement procedures will have the highest CAGR during the forecast period.

On the basis of procedure types, this market is categorized into repair and replacement procedures. The repair procedures segment is further segmented into valvuloplasty, transcatheter mitral valve repair (TMVR), annuloplasty, and others, whereas the replacement procedures segment is studied for tissue heart valves, mechanical heart valves, and transcatheter aortic valve replacement (TAVR). The demand for replacement procedures is anticipated to be the highest during the forecast period. The key factor attributed to the growth of this segment is consistent growth in the geriatric population with high vulnerability to debilitating cardiovascular diseases. Improved long-term durability, the growing uptake of minimally invasive and transcatheter procedures, and competitive prices of replacement devices further drive the growth of this segment.

North America will dominate the global structural heart devices market.

Significantly high disease incidence, the rapid introduction of novel, breakthrough repair and replacement devices and procedures, along with favorable reimbursements for the already established procedures are the key factors driving the dominance of the North American market on the global front. Additionally, this region is also characterized by the domicile of the major market incumbents, therefore ensuring the early introduction of novel devices in the market. Asia Pacific, on the other hand, is expected to witness the fastest market growth during the forecast period. Increasing regulatory approvals, improving reimbursements, and the growing involvement of government funding in public healthcare are collectively driving the Asia-Pacific market. Recognizing such opportunities, market players with a stronghold in developed regions are expanding their footprints in Asia-Pacific. Distribution agreements, the establishment of manufacturing facilities, and research collaborations are the key strategic events observed in the region.

Periods of History and Forecast

This research report presents the analysis of each considered segment for the period from 2016 to 2026, using 2017 as the base year for estimations. Compounded annual growth rates (CAGRs) for each segment are calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The structural heart devices market report provides a quantitative assessment of the industry in terms of current and forecasted market size while also presenting the market dynamics. This market is segmented based on device type, procedure, and geography.

As mentioned, this report offers market size and forecasts for each market segment considered in the study scope for the period from 2016 to 2026. Furthermore, quantitative information sets for each such segment are provided in the study for better market analysis. Analytical factors such as drivers, challenges, and opportunities are also covered in this report. In addition, this report provides profiles of key players operating in this market, such as Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation, Medtronic PLC, LivaNova PLC, C. R. Bard, Inc., CryoLife, Inc., Integer Holdings Corporation, Comed B.V., and JenaValve Technology, Inc.

Key questions are answered in this report.

  • What are the most promising growth opportunities and drivers prevailing in the global structural heart devices market?
  • Which product segment is estimated to generate the largest revenue?
  • What are the major factors influencing global market growth during the forecast period?
  • Who are the major players operating in the global structural heart devices market, and which companies are bingeing on the latest developments in the industry?
  • Which are the key competing products in the global market for structural heart devices?
  • Which region will progress with the fastest growth rate during the forecast period?

Frequently Asked Questions:

The market for Structural Heart Devices Market is expected to reach US$ XX Mn by 2026.

The Structural Heart Devices Market is expected to see significant CAGR growth over the coming years, at XX%.

The report is forecasted from 2018-2026.

The base year of this report is 2017.

Boston Scientific Corporation, Edwards Lifesciences Corporation, Medtronic PLC, LivaNova PLC, C. R. Bard, Inc., CryoLife, Inc., Integer Holdings Corporation, Comed B.V. are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Jan 2019
Category:  Medical Devices
Report ID:   59510
Report Format:   PDF
Pages:   120
Rating:    4.1 (69)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support